Eltrombopag 25mg Tablet Manufacturer Supplier in India – Why Taj Pharma is the Preferred Exporter for Global Buyers

Introduction to Eltrombopag 25mg Tablet

Eltrombopag 25mg Tablet, marketed under the brand name Orken, is a breakthrough pharmaceutical product used to manage thrombocytopenia (low platelet count) in patients with chronic immune thrombocytopenia (ITP), chronic hepatitis C virus (HCV) infection, and severe aplastic anemia. As a thrombopoietin receptor agonist, Eltrombopag stimulates platelet production, helping patients maintain adequate platelet levels to reduce the risk of bleeding.

Taj Pharma, headquartered in Vapi, Gujarat, India, is a leading manufacturer, exporter, and supplier of high-quality Eltrombopag 25mg Tablets, catering to global markets including Africa, the Middle East, and LATAM regions.


Why Choose Taj Pharma as Your Eltrombopag 25mg Tablet Supplier?

1. World-Class Manufacturing Standards

Taj Pharma adheres to WHO-GMP and ISO-certified manufacturing protocols, ensuring that every batch of Eltrombopag 25mg Tablet meets stringent quality requirements. The company utilizes advanced formulation technologies to guarantee consistent bioavailability and therapeutic efficacy.

2. Comprehensive Quality Assurance

Every tablet undergoes rigorous testing at state-of-the-art laboratories to ensure purity, potency, and safety. Taj Pharma’s quality control measures include:

  • Raw material verification
  • In-process monitoring
  • Finished product analysis
  • Stability studies

These processes ensure that Eltrombopag 25mg Tablet is free from impurities and meets global regulatory standards.

3. Extensive Export Network

Taj Pharma has a robust global supply chain, exporting Eltrombopag 25mg Tablets to multiple international markets, including:

  • Africa
  • Middle East
  • LATAM

With expertise in logistics and regulatory compliance, Taj Pharma guarantees timely delivery and smooth import-export procedures for international buyers.


Therapeutic Applications of Eltrombopag 25mg Tablet

Eltrombopag 25mg Tablet plays a crucial role in the treatment of conditions associated with low platelet counts. Its therapeutic applications include:

1. Chronic Immune Thrombocytopenia (ITP)

  • Stimulates platelet production in patients with autoimmune platelet destruction.
  • Reduces the risk of spontaneous bleeding and associated complications.
  • Suitable for adults and pediatric patients resistant to conventional therapies.

2. Chronic Hepatitis C Virus (HCV) Infection

  • Prevents treatment interruptions caused by thrombocytopenia in HCV patients receiving interferon-based therapy.
  • Ensures that patients maintain optimal platelet levels during antiviral therapy.

3. Severe Aplastic Anemia

  • Acts as a supportive treatment to enhance platelet count in patients unresponsive to standard immunosuppressive therapy.

Mechanism of Action of Eltrombopag

Eltrombopag is a non-peptide thrombopoietin receptor agonist. Its mechanism includes:

  1. Binding to thrombopoietin receptors on megakaryocyte precursors.
  2. Stimulating the proliferation and differentiation of megakaryocytes.
  3. Enhancing platelet production in the bone marrow.

This mechanism ensures a sustained increase in platelet count while minimising the risk of excessive thrombosis when used under medical supervision.


Dosage and Administration Guidelines

For optimal efficacy and safety, patients should follow these administration instructions:

  • Dosage: As prescribed by a healthcare professional, typically 25mg once daily.
  • Timing: Can be taken on an empty stomach, preferably at the same time each day.
  • Administration: Swallow tablets whole; do not chew, crush, or break.
  • Monitoring: Regular platelet counts and liver function tests are recommended during therapy.

Safety Profile and Side Effects

Eltrombopag 25mg Tablet is generally well-tolerated. Common side effects include:

  • Nausea and vomiting
  • Diarrhea
  • Upper respiratory tract infections
  • Urinary tract infections

Patients should consult their physician if any side effects persist or worsen. Dose adjustments may be necessary for individuals with liver disorders, and it is essential to disclose all concurrent medications to the prescribing doctor.


Taj Pharma’s Commitment to Quality and Compliance

1. Regulatory Compliance

Taj Pharma ensures all Eltrombopag 25mg Tablets comply with:

  • Indian FDA regulations
  • WHO-GMP standards
  • International pharmacopoeial guidelines

This ensures that every tablet is safe, effective, and suitable for global markets.

2. Advanced Packaging and Shelf Life

  • Blister packing and high-quality bottles to maintain stability.
  • Extended shelf life with optimal storage conditions.
  • Tamper-evident packaging for secure transportation.

3. Dedicated Customer Support

Taj Pharma provides professional guidance to buyers, including:

  • Regulatory documentation for export
  • Product specifications and certifications
  • Marketing and promotional support for PCD Pharma franchisees

PCD Pharma Franchise Opportunities with Eltrombopag 25mg Tablet

Taj Pharma offers PCD Pharma Franchise opportunities, enabling entrepreneurs to distribute Eltrombopag 25mg Tablet across India. Franchise benefits include:

  • Monopoly rights in selected territories
  • Competitive pricing and high-profit margins
  • Marketing and promotional assistance
  • Continuous supply of quality medicines

Global Recognition and Export Excellence

Taj Pharma has established itself as a trusted exporter of Eltrombopag 25mg Tablets, with recognition in multiple international markets. Key highlights include:

  • Consistent on-time delivery for bulk orders
  • Strong partnerships with wholesalers and distributors
  • Commitment to sustainable and eco-friendly practices in production

Eltrombopag 25mg Tablet by Taj Pharma represents a trusted, high-quality solution for managing thrombocytopenia and other platelet-related disorders. With superior manufacturing standards, comprehensive quality control, extensive export capabilities, and dedicated customer support, Taj Pharma remains the preferred manufacturer, supplier, and exporter for global buyers seeking reliable Eltrombopag 25mg Tablets. Taj Pharma continues to uphold its promise of premium pharmaceutical products, ensuring patients worldwide have access to safe and effective treatments.